GR2301 Injection

· Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GR2301 Injection, covering 2025-09-24 to 2025-09-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety of GR2301 Injection in Healthy Volunteers. [Phase 1]